Showing 1071-1080 of 3550 results for "".
Dupilumab For the Management of Pembrolizumab-induced Rash: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/dupilumab-for-the-management-of-pembrolizumab-induced-rash-a-case-report/23841/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/23510/New Products
https://practicaldermatology.com/columns/new-products/new-products/20668/Currents
https://practicaldermatology.com/topics/practice-management/currents/20575/Aesthetic developments herald the dawn of a new age of rejuvenation.Currents
https://practicaldermatology.com/topics/practice-management/currents/21012/CSF After Dark
https://practicaldermatology.com/topics/practice-management/csf-after-dark/20404/What happens in Vegas stays in Vegas. Or does it?Reassessing Topical 5-Fluorouracil for AK Management
https://practicaldermatology.com/topics/practice-management/reassessing-topical-5-fluorouracil-for-ak-management/21021/New research highlights the beneficial role of this therapeutic mainstay, alone and in combination with lesion-directed treatment.Highlights from NewDerm LIVE
https://practicaldermatology.com/youngmd-connect/resident-resource-center/highlights-from-newderm-live/21097/Noah Worcester 2024: Dr. Green and Dr. Weinstein on Medicare
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-green-and-dr-weinstein-medicare/24582/Noah Worcester 2024: Dr. Green and Dr. Weinstein on MedicareTherapeutics Update
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/theraputics-update/20510/New products and pharmacologic developments